Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)

China flag China · Delayed Price · Currency is CNY
62.88
+1.13 (1.83%)
Mar 10, 2026, 10:05 AM CST
17.38%
Market Cap 8.02B
Revenue (ttm) 1.21B
Net Income (ttm) 181.86M
Shares Out 129.95M
EPS (ttm) 1.40
PE Ratio 44.12
Forward PE n/a
Dividend 1.00 (1.61%)
Ex-Dividend Date May 20, 2025
Volume 747,053
Average Volume 1,712,368
Open 60.98
Previous Close 61.75
Day's Range 60.98 - 63.49
52-Week Range 50.02 - 94.30
Beta 0.57
RSI 26.61
Earnings Date Apr 28, 2026

About SHE:300841

Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines. In addition, it exports its products. Chengdu Kanghua Biological Products Co., Ltd. was founded in 2004 and is based in Chengdu, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 620
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300841
Full Company Profile

Financial Performance

In 2024, SHE:300841's revenue was 1.43 billion, a decrease of -9.23% compared to the previous year's 1.58 billion. Earnings were 398.65 million, a decrease of -21.71%.

Financial Statements

News

There is no news available yet.